Commentary

Waitr's post-SPAC performance triggers litigation, Warburg locks down buyer for Hygiena

SPAC boom leads to litigation and Warburg exits Hygiena.

RLH gears up to sell ClearView, Diversis' ServicePower on the sale block, Ares chief says SPACs impact PE dealflow

Diversis Capital is preparing to sell ServicePower and more than $28 billion has been raised across 100 SPAC IPOs this year alone.

Riata Capital sees opportunity in residential services, Blackstone's Bumble rallies in public debut, final day for Deal Award submissions

Riata Capital invests in Greenix Pest Control and Blackstone-backed dating app Bumble pops in IPO debut.

Sun Capital eyes agtech, Apollo SPAC raises $600m, Oaktree and Advent back Thrasio

Sun Capital Partners is looking to grow Calcium Products and Cresset adds ex-Goldman Sachs VP to team.

PE-backed software companies Precisely and Therapy Brands evaluate sales, Apollo makes preferred investment in US Acute Care

Centerbridge Partners and Clearlake Capital are exploring a sale of Precisely and Apollo commits to invest up to $470 million in US Acute Care Solutions.

Bain Capital, Cinven carve-out Swiss-based Lonza unit, BC Partners' Appgate unveils $1bn merger, Wells Fargo bets on telepsychiatry

Wells Fargo Strategic Capital leads $24 million investment in Array Behavioral Care and and Appgate, a cybersecurity company backed by BC Partners and Medina Capital, is going public with merger.

Audax-backed Gastro Health, Insight Partners' Thycotic ready for sales, Deal Award deadline approaches

Audax Private Equity prepares to sell Gastro Health and the same goes for Thycotic, owned by Insight Partners.

Riverside's ARCOS explores sale, KKR files for $1bn SPAC, Blue Ox Healthcare Partners CEO and Blue Wolf-spinout talk strategy

Riverside Company is preparing to sell ARCOS and KKR files for a $1 billion SPAC.

Carlyle found the exit door in 2020, Arcline closes big sophomore fund, Aquiline invests in National Medical Billing Services

Arcline closed its sophomore fund at $2.75 billion and Carlyle invested $11.1 billion for full-year 2020.

Certain uncertainty: 2021 PE transaction trends

This year will continue to see flexible, de-risked deal structures.